UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________

FORM 10-Q

____________________________

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________to___________

Commission File Number: 001-38095

____________________________

Ingersoll Rand Inc.

(Exact Name of Registrant as Specified in Its Charter)

____________________________

Delaware	46-2393770
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

525 Harbour Place Drive, Suite 600

Davidson, North Carolina 28036

(Address of Principal Executive Offices) (Zip Code)

(704) 655-4000

(Registrant’s Telephone Number, Including Area Code)

____________________________

Securities Registered Pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, $0.01 Par Value per share	IR	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities

Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ý  No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ý  No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	ý	Accelerated filer	☐	Emerging growth Company	☐
Non-accelerated filer	☐	Smaller reporting company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ý

The registrant had outstanding 403,431,881 shares of Common Stock, par value $0.01 per share, as of April 26, 2024.

INGERSOLL RAND INC. AND SUBSIDIARIES

FORM 10-Q

INDEX

	Page No.
PART I. FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements	5
Condensed Consolidated Statements of Operations (Unaudited)	5
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)	6
Condensed Consolidated Balance Sheets (Unaudited)	7
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)	8
Condensed Consolidated Statements of Cash Flows (Unaudited)	9
Note 1. Basis of Presentation and Recent Accounting Pronouncements	10
Note 2. Acquisitions	10
Note 3. Restructuring	12
Note 4. Allowance for Credit Losses	13
Note 5. Inventories	13
Note 6. Goodwill and Other Intangible Assets	13
Note 7. Supply Chain Finance Program	14
Note 8. Accrued Liabilities	14
Note 9. Benefit Plans	15
Note 10. Debt	15
Note 11. Stock-Based Compensation Plans	17
Note 12. Accumulated Other Comprehensive Loss	19
Note 13. Hedging Activities and Derivative Instruments	20
Note 14. Fair Value Measurements	22
Note 15. Revenue from Contracts with Customers	24
Note 16. Income Taxes	26
Note 17. Other Operating Expense, Net	26
Note 18. Contingencies	26
Note 19. Segment Results	27
Note 20. Earnings Per Share	28
Note 21. Subsequent Event	29
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
Item 3. Quantitative and Qualitative Disclosures About Market Risk	40
Item 4. Controls and Procedures	40
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	41
Item 1A. Risk Factors	41
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	41
Item 3. Defaults Upon Senior Securities	41
Item 4. Mine Safety Disclosures	41
Item 5. Other Information	41
Item 6. Exhibits	42
SIGNATURES	43

2

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

In addition to historical information, this Form 10-Q may contain “forward-looking statements” within the meaning of the “safe harbor provisions” of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts included in this Form 10-Q, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, results of operations, financial position, business outlook, business trends and other information, may be forward-looking statements. Words such as “estimates,” “expects,” “contemplates,” “will,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “forecasts,” “may,” “should” and variations of such words or similar expressions are intended to identify forward-looking statements. The forward-looking statements are not historical facts, and are based upon our current expectations, beliefs, estimates and projections, and various assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, estimates and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.

There are a number of risks, uncertainties and other important factors, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking statements contained in this Form 10-Q. Such risks, uncertainties and other important factors that could cause actual results to differ include, among others, the risks, uncertainties and factors set forth under “Part I, Item 1A. Risk Factors” and “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Annual Report”) and under “Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Form 10-Q, as such risk factors may be updated from time to time in our periodic filings with the SEC, and are accessible on the SEC’s website at www.sec.gov, and also include the following:

•We have exposure to the risks associated with instability in the global economy and financial markets, which may negatively impact our revenues, liquidity, suppliers and customers.

•Information systems failure or disruption, due to cyber terrorism or other actions, may adversely impact our business and result in financial loss to the Company or liability to our customers.

•More than half of our sales and operations are in non-U.S. jurisdictions and we are subject to the economic, political, regulatory and other risks of international operations.

•A natural disaster, catastrophe, pandemic, geopolitical tensions or other event could adversely affect our operations.

•Large or rapid increases in the cost of raw materials and component parts, substantial decreases in their availability or our dependence on particular suppliers of raw materials and component parts could materially and adversely affect our operating results.

•We face competition in the markets we serve, which could materially and adversely affect our operating results.

•Shareholder, customer and regulatory agency emphasis on environmental, social, and governance responsibility may impose additional costs on us or expose us to new risks.

•Acquisitions, including integrating such acquisitions, and dispositions create certain risks and may affect our operating results.

•Our results of operations are subject to exchange rate and other currency risks. A significant movement in exchange rates could adversely impact our results of operations and cash flows.

•If we are unable to develop new products and technologies, our competitive position may be impaired, which could materially and adversely affect our sales and market share.

•Our business could suffer if we experience employee work stoppages, union and work council campaigns or other labor difficulties.

•Changes in tax or other laws, regulations, or adverse determinations by taxing or other governmental authorities could increase our effective tax rate and cash taxes paid or otherwise affect our financial condition or operating results.

•Our success depends on our ability to attract, retain and develop key personnel and other talent throughout the Company.

•The risk of non-compliance with U.S. and foreign laws and regulations applicable to our international operations could have a significant impact on our results of operations, financial condition or strategic objectives.

•Third parties may infringe upon our intellectual property or may claim we have infringed their intellectual property, and we may expend significant resources enforcing or defending our rights or suffer competitive injury.

•The loss of, or disruption in, our distribution network could have a negative impact on our abilities to ship products, meet customer demand and otherwise operate our business.

•Our ongoing and expected restructuring plans and other cost savings initiatives may not be as effective as we anticipate, and we may fail to realize the cost savings and increased efficiencies that we expect to result from these actions. Our operating results could be negatively affected by our inability to effectively implement such restructuring plans and other cost savings initiatives.

3

•Cost overruns, delays, penalties or liquidated damages could negatively impact our results, particularly with respect to fixed-price contracts for custom engineered products.

•Our operating results could be adversely affected by a loss or reduction of business with key customers or consolidation or the vertical integration of our customer base.

•Credit and counterparty risks could harm our business.

•We are a defendant in certain asbestos and silica-related personal injury lawsuits, which could adversely affect our financial condition.

•The nature of our products creates the possibility of significant product liability and warranty claims, which could harm our business.

•A significant portion of our assets consists of goodwill and other intangible assets, the value of which may be reduced if we determine that those assets are impaired.

•Environmental compliance costs and liabilities could adversely affect our financial condition.

•We face risks associated with our pension and other postretirement benefit obligations.

•Our indebtedness could have important adverse consequences and adversely affect our financial condition.

•We may not be able to generate sufficient cash to service all of our indebtedness, and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful.

•Despite our level of indebtedness, we and our subsidiaries may still be able to incur substantially more debt, including off-balance sheet financing, contractual obligations and general and commercial liabilities. This could further exacerbate the risks to our financial condition.

•The terms of the credit agreement governing the Senior Secured Credit Facilities (as amended, the “Credit Agreement”) may restrict our current and future operations, particularly our ability to respond to changes or to take certain actions.

•Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.

•We utilize derivative financial instruments to reduce our exposure to market risks from changes in interest rates on our variable rate indebtedness and we will be exposed to risks related to counterparty credit worthiness or non-performance of these instruments.

•If the financial institutions that are part of the syndicate of our Revolving Credit Facility (as defined herein) fail to extend credit under our Revolving Credit Facility, our liquidity and results of operations may be adversely affected.

We caution you that the risks, uncertainties and other factors referenced above may not contain all of the risks, uncertainties and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors’ likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) our strategy, which is based in part on this analysis, will be successful. All forward-looking statements in this report apply only as of the date of this report or as of the date they were made and, except as required by applicable law, we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise.

All references to “we,” “us,” “our,” the “Company” or “Ingersoll Rand” in this Quarterly Report on Form 10-Q mean Ingersoll Rand Inc. and its subsidiaries, unless the context otherwise requires.

Website Disclosure

We use our website www.irco.com as a channel of distribution of Company information. Financial and other important information regarding us is routinely accessible through and posted on our website. Accordingly, investors should monitor our website, in addition to following our press releases, SEC filings and public conference calls and webcasts. In addition, you may automatically receive e-mail alerts and other information about Ingersoll Rand Inc. when you enroll your email address by visiting the “Investor Alerts” section of our website at investors.irco.com. The contents of our website are not, however, a part of this Quarterly Report on Form 10-Q.

4

PART I.    FINANCIAL INFORMATION

ITEM 1.    CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

INGERSOLL RAND INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited; in millions, except per share amounts)

	For the Three Month Period Ended March 31,
	2024		2023
Revenues	$	1,670.1	$	1,629.3
Cost of sales	923.8		965.1
Gross Profit	746.3		664.2
Selling and administrative expenses	336.3		311.1
Amortization of intangible assets	91.6		92.4
Other operating expense, net	25.2		20.4
Operating Income	293.2		240.3
Interest expense	36.8		38.9
Other income, net	(13.2)		(9.6)
Income Before Income Taxes	269.6		211.0
Provision for income taxes	54.4		48.1
Income (loss) on equity method investments	(10.7)		0.3
Net Income	204.5		163.2
Less: Net income attributable to noncontrolling interests	2.3		2.1
Net Income Attributable to Ingersoll Rand Inc.	$	202.2	$	161.1
Basic earnings per share	0.50		0.40
Diluted earnings per share	0.50		0.39

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

INGERSOLL RAND INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited; in millions)

	For the Three Month Period Ended March 31,
	2024		2023
Comprehensive Income Attributable to Ingersoll Rand Inc.
Net income attributable to Ingersoll Rand Inc.	$	202.2	$	161.1
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments, net	(73.5)		30.8
Unrecognized loss on cash flow hedges	(0.1)		(5.3)
Pension and other postretirement prior service cost and gain (loss), net	(1.4)		(0.2)
Total other comprehensive income (loss), net of tax	(75.0)		25.3
Comprehensive income attributable to Ingersoll Rand Inc.	$	127.2	$	186.4
Comprehensive Income Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests	$	2.3	$	2.1
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments, net	(0.8)		0.9
Total other comprehensive income (loss), net of tax	(0.8)		0.9
Comprehensive income attributable to noncontrolling interests	1.5		3.0
Total Comprehensive Income	$	128.7	$	189.4

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

INGERSOLL RAND INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited; in millions, except share amounts)

	March 31, 2024		December 31, 2023
Assets
Current assets:
Cash and cash equivalents	$	1,452.3	$	1,595.5
Accounts receivable, net of allowance for credit losses of $55.3 and $53.8, respectively	1,245.2		1,234.2
Inventories	1,051.8		1,001.1
Other current assets	257.5		219.6
Total current assets	4,006.8		4,050.4
Property, plant and equipment, net of accumulated depreciation of $518.5 and $500.8, respectively	742.2		711.4
Goodwill	6,609.9		6,609.7
Other intangible assets, net	3,589.6		3,611.1
Deferred tax assets	32.7		31.5
Other assets	547.8		549.4
Total assets	$	15,529.0	$	15,563.5
Liabilities and Stockholders’ Equity
Current liabilities:
Short-term borrowings and current maturities of long-term debt	$	31.3	$	30.6
Accounts payable	694.0		801.2
Accrued liabilities	999.3		995.5
Total current liabilities	1,724.6		1,827.3
Long-term debt, less current maturities	2,687.0		2,693.0
Pensions and other postretirement benefits	149.5		150.0
Deferred income tax liabilities	624.2		612.6
Other liabilities	424.0		433.9
Total liabilities	$	5,609.3	$	5,716.8
Commitments and contingencies (Note 18)	—		—
Stockholders’ equity
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 429,651,459 and 428,589,061 shares issued as of March 31, 2024 and December 31, 2023, respectively	4.3		4.3
Capital in excess of par value	9,569.8		9,550.8
Retained earnings	1,891.3		1,697.2
Accumulated other comprehensive loss	(302.6)		(227.6)
Treasury stock at cost; 25,926,540 and 25,241,667 shares as of March 31, 2024 and December 31, 2023, respectively	(1,307.5)		(1,240.9)
Total Ingersoll Rand Inc. stockholders’ equity	$	9,855.3	$	9,783.8
Noncontrolling interests	64.4		62.9
Total stockholders’ equity	$	9,919.7	$	9,846.7
Total liabilities and stockholders’ equity	$	15,529.0	$	15,563.5

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

INGERSOLL RAND INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited; in millions)

	Three Month Period Ended March 31, 2024
	Common Stock			Capital in Excess of Par Value		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Stock		Total Ingersoll Rand Inc. Stockholders’ Equity		Noncontrolling Interests		Total Equity
	Shares Issued	Par
Balance at beginning of period	428.6	$	4.3	$	9,550.8	$	1,697.2	$	(227.6)	$	(1,240.9)	$	9,783.8	$	62.9	$	9,846.7
Net income	—	—		—		202.2		—		—		202.2		2.3		204.5
Dividends declared	—	—		—		(8.1)		—		—		(8.1)		—		(8.1)
Issuance of common stock for stock-based compensation plans	1.1	—		10.1		—		—		—		10.1		—		10.1
Purchases of treasury stock	—	—		—		—		—		(72.9)		(72.9)		—		(72.9)
Issuance of treasury stock for stock-based compensation plans	—	—		(5.2)		—		—		6.3		1.1		—		1.1
Stock-based compensation	—	—		14.1		—		—		—		14.1		—		14.1
Other comprehensive loss, net of tax	—	—		—		—		(75.0)		—		(75.0)		(0.8)		(75.8)
Balance at end of period	429.7	$	4.3	$	9,569.8	$	1,891.3	$	(302.6)	$	(1,307.5)	$	9,855.3	$	64.4	$	9,919.7

	Three Month Period Ended March 31, 2023
	Common Stock			Capital in Excess of Par Value		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Stock		Total Ingersoll Rand Inc. Stockholders’ Equity		Noncontrolling Interests		Total Equity
	Shares Issued	Par
Balance at beginning of period	426.3	$	4.3	$	9,476.8	$	950.9	$	(251.7)	$	(984.5)	$	9,195.8	$	61.4	$	9,257.2
Net income	—	—		—		161.1		—		—		161.1		2.1		163.2
Dividends declared	—	—		—		(8.1)		—		—		(8.1)		—		(8.1)
Issuance of common stock for stock-based compensation plans	1.2	—		8.7		—		—		—		8.7		—		8.7
Purchases of treasury stock	—	—		—		—		—		(77.0)		(77.0)		—		(77.0)
Issuance of treasury stock for stock-based compensation plans	—	—		(3.3)		—		—		3.4		0.1		—		0.1
Stock-based compensation	—	—		11.4		—		—		—		11.4		—		11.4
Other comprehensive income, net of tax	—	—		—		—		25.3		—		25.3		0.9		26.2
Balance at end of period	427.5	$	4.3	$	9,493.6	$	1,103.9	$	(226.4)	$	(1,058.1)	$	9,317.3	$	64.4	$	9,381.7

The accompanying notes are an integral part of these condensed consolidated financial statements.

8

INGERSOLL RAND INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; in millions)

	For the Three Month Period Ended March 31,
	2024		2023
Cash Flows From Operating Activities:
Net income	$	204.5	$	163.2
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of intangible assets	91.6		92.4
Depreciation	25.6		21.6
Non-cash restructuring charges	—		0.9
Stock-based compensation expense	14.1		12.1
Loss (income) on equity method investments	10.7		(0.3)
Foreign currency transaction losses (gains), net	(0.7)		1.0
Non-cash adjustments to carrying value of LIFO inventories	6.7		7.8
Other non-cash adjustments	1.4		2.9
Changes in assets and liabilities:
Receivables	(11.5)		(83.7)
Inventories	(58.2)		(45.3)
Accounts payable	(101.5)		(70.6)
Accrued liabilities	(1.8)		56.5
Other assets and liabilities, net	(19.3)		11.8
Net cash provided by operating activities	161.6		170.3
Cash Flows Used In Investing Activities:
Capital expenditures	(62.3)		(22.4)
Net cash paid in acquisitions	(143.3)		(566.4)
Disposals of property, plant and equipment	—		7.3
Net cash used in investing activities	(205.6)		(581.5)
Cash Flows Used In Financing Activities:
Principal payments on long-term debt	(7.1)		(11.0)
Purchases of treasury stock	(72.9)		(77.0)
Cash dividends on common shares	(8.1)		(8.1)
Proceeds from stock option exercises	11.2		9.2
Payments of deferred and contingent acquisition consideration	(2.2)		(1.9)
Other financing	(0.5)		(0.5)
Net cash used in financing activities	(79.6)		(89.3)
Effect of exchange rate changes on cash and cash equivalents	(19.6)		6.8
Net decrease in cash and cash equivalents	(143.2)		(493.7)
Cash and cash equivalents, beginning of period	1,595.5		1,613.0
Cash and cash equivalents, end of period	$	1,452.3	$	1,119.3
Supplemental Cash Flow Information
Cash paid for income taxes, net of refunds	$	43.5	$	19.1
Cash paid for interest, net of interest rate derivative settlements	58.2		36.1

The accompanying notes are an integral part of these condensed consolidated financial statements.

9

INGERSOLL RAND INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited; in millions, except share and per share amounts)

Note 1. Basis of Presentation and Recent Accounting Pronouncements

Basis of Presentation

Ingersoll Rand Inc. is a diversified, global provider of mission-critical flow creation products and industrial solutions. The accompanying condensed consolidated financial statements include the accounts of Ingersoll Rand Inc. and its majority-owned subsidiaries (collectively referred to herein as “Ingersoll Rand” or the “Company”).

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial reporting, the instructions for Form 10-Q and Article 10 of the U.S. Securities and Exchange Commission (“SEC”) Regulation S-X. In the Company’s opinion, the condensed consolidated financial statements reflect all adjustments of a normal recurring nature necessary for a fair statement of the results for the interim periods presented. The condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 (“2023 Annual Report”).

The results of operations for the three month period ended March 31, 2024 are not necessarily indicative of future results.

Recently Issued Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segments expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments in this update should be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. The adoption will modify our disclosures but is not expected to have a material effect on our consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual statements that have not yet been issued or made available for issuance. The amendments in this update should be applied on a prospective basis. Retrospective application is permitted. The adoption will modify our disclosures but is not expected to have a material effect on our consolidated financial statements.

Note 2. Acquisitions

Acquisitions in 2024

On February 1, 2024, the Company completed the acquisition of Friulair S.r.l. (“Friulair”) for initial cash consideration of $142.2 million and contingent consideration of up to approximately $11.0 million. The business is a manufacturer of dryers, filters, aftercoolers, and accessories for the treatment of compressed air and its chiller product line. The acquisition is intended increase the scale of the Company’s air dryer business and will add new chiller production capabilities. Friulair has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. Substantially all of this goodwill is not expected to be deductible for tax purposes.

Other acquisitions completed during the three months ended March 31, 2024 include a manufacturer of vacuum pumps and accessories, substantially all of which have been reported within the Industrial Technologies and Services segment. The aggregate consideration for this acquisition was $1.4 million.

The following table summarizes the allocation of consideration for all businesses acquired in the first quarter of 2024 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for acquisitions completed

10

in the first quarter, including Friulair, is preliminary, and amounts assigned to acquired assets and liabilities assumed are subject to change as information necessary to complete the analysis is obtained.

	Friulair		All Others		Total
Accounts receivable	$	14.9	$	—	$	14.9
Inventories	13.2		0.3		13.5
Other current assets	0.5		—		0.5
Property, plant and equipment	7.7		0.1		7.8
Goodwill	44.9		1.0		45.9
Other intangible assets	84.5		—		84.5
Other assets	0.3		—		0.3
Total current liabilities	(14.5)		—		(14.5)
Other noncurrent liabilities	(2.8)		—		(2.8)
Total consideration	$	148.7	$	1.4	$	150.1

The aggregate revenue and operating income included in the condensed consolidated financial statements for these acquisitions subsequent to the dates of acquisition was $11.3 million and $0.5 million for the three month period ended March 31, 2024, respectively. The operating income of these acquired businesses includes the effects of acquisition-related accounting adjustments such as amortization of intangible assets.

Transaction with ILC Dover

On March 25, 2024, the Company entered into an agreement to acquire ILC Dover from New Mountain Capital, LLC for an upfront all-cash purchase price of approximately $2.325 billion and contingent consideration of up to $75.0 million. ILC Dover’s offerings include solutions for biopharmaceutical, pharmaceutical, and medical device markets as well as products for the space industry and will be reported in the Precision and Science Technologies segment. This transaction is expected to close in the second quarter of 2024, subject to customary regulatory approvals and closing conditions.

Acquisitions in 2023

On January 3, 2023, the Company completed the acquisition of SPX FLOW’s Air Treatment business (“Air Treatment”) for cash consideration of $519.0 million. The business is a manufacturer of desiccant and refrigerated dryers, filtration systems and purifiers for dehydration in compressed air. The acquisition is intended to expand the Company’s offerings of compressor system components through globally recognized brands. The Air Treatment business has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. Substantially all of this goodwill is not expected to be deductible for tax purposes.

On February 1, 2023, the Company acquired Paragon Tank Truck Equipment (“Paragon”), a provider of solutions used for loading and unloading dry bulk and liquid tanks on and off of trucks, for cash consideration of $42.2 million. Paragon has been reported within the Industrial Technologies and Services segment.

On April 1, 2023, the Company acquired EcoPlant Technological Innovation Ltd. (“EcoPlant”), for initial cash consideration of $29.5 million and contingent consideration of up to $17.0 million. EcoPlant is a provider of a software-as-a-service platform that dynamically controls compressed air systems to optimize performance and resource consumption. EcoPlant has been reported within the Industrial Technologies and Services segment.

On August 18, 2023, the Company completed the acquisition of Howden Roots LLC (“Roots”), for cash consideration of $290.0 million. Roots is a leading manufacturer of engineered rotary and centrifugal blowers with an iconic brand developed over more than 160 years. The acquisition is intended to expand the Company’s blower product portfolio and benefit from Roots’ robust technical capabilities and exposure to growing sustainability-related applications. Roots has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. This goodwill is expected to be deductible for tax purposes.

The Company acquired 10 additional businesses in 2023 for aggregate consideration of $83.7 million. These primarily consist of manufacturers and distributors of existing and adjacent offerings in the Industrial Technologies and Services segment.

11

The following table summarizes the allocation of consideration for all businesses acquired in 2023 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for Air Treatment is complete. Initial accounting for all other acquisitions completed in 2023, including Roots, is substantially complete and any further measurement period adjustments are not expected to be material.

	Air Treatment		Roots		All Others		Total
Accounts receivable	$	26.1	$	14.5	$	11.7	$	52.3
Inventories	43.9		34.2		21.0		99.1
Other current assets	2.1		2.9		6.2		11.2
Property, plant and equipment	18.4		42.0		5.0		65.4
Goodwill	279.9		104.0		125.7		509.6
Other intangible assets	238.6		116.9		25.4		380.9
Other assets	7.6		4.5		0.4		12.5
Total current liabilities	(35.9)		(26.9)		(19.2)		(82.0)
Deferred tax liabilities	(54.8)		—		(3.7)		(58.5)
Other noncurrent liabilities	(6.9)		(2.1)		(4.3)		(13.3)
Total consideration	$	519.0	$	290.0	$	168.2	$	977.2

The revenues included in the condensed consolidated financial statements for these acquisitions subsequent to their date of acquisition was $95.6 million and $48.4 million for the three month periods ended March 31, 2024 and 2023, respectively. The operating income included in the condensed consolidated financial statements for these acquisitions subsequent to their date of acquisition was $11.5 million and $3.2 million for the three month periods ended March 31, 2024 and 2023, respectively. The operating income of these acquired businesses include the effects of acquisition-related accounting adjustments such as amortization of intangible assets and fair value adjustments to acquired inventory.

Note 3. Restructuring

2024 and 2023 Actions

The Company continues to undertake restructuring actions to optimize our cost structure. Charges incurred from actions taken in 2024 and 2023 include workforce restructuring, facility consolidation and other exit and disposal costs.

For the three month periods ended March 31, 2024 and 2023, “Restructuring charges, net” were recognized within “Other operating expense, net” in the Condensed Consolidated Statement of Operations and consisted of the following.

	For the Three Month Period Ended March 31,
	2024		2023
Industrial Technologies and Services	$	5.1	$	3.1
Precision and Science Technologies	4.4		(0.4)
Corporate	0.2		0.2
Restructuring charges, net	$	9.7	$	2.9

The following table summarizes the activity associated with the Company’s restructuring programs for the three month periods ended March 31, 2024 and 2023.

	For the Three Month Period Ended March 31,
	2024		2023
Balance at beginning of period	$	15.5	$	14.9
Charged to expense - termination benefits	9.3		0.9
Charged to expense - other (1)	0.4		1.1
Payments	(4.3)		(3.6)
Currency translation adjustment and other	(0.3)		0.1
Balance at end of period	$	20.6	$	13.4

12

(1)Excludes $0.9 million of non-cash charges that impacted restructuring expense but not the restructuring liabilities during the three month period ended March 31, 2023.

Note 4. Allowance for Credit Losses

The allowance for credit losses for the three month periods ended March 31, 2024 and 2023 consisted of the following.

	For the Three Month Period Ended March 31,
	2024		2023
Balance at beginning of the period	$	53.8	$	47.2
Provision charged to expense	2.5		4.0
Write-offs, net of recoveries	(0.3)		(0.4)
Foreign currency translation and other	(0.7)		0.2
Balance at end of the period	$	55.3	$	51.0

Note 5. Inventories

Inventories as of March 31, 2024 and December 31, 2023 consisted of the following.

	March 31, 2024		December 31, 2023
Raw materials, including parts and subassemblies	$	657.9	$	590.7
Work-in-process	137.5		145.1
Finished goods	335.6		337.8
	1,131.0		1,073.6
LIFO reserve	(79.2)		(72.5)
Inventories	$	1,051.8	$	1,001.1

Note 6. Goodwill and Other Intangible Assets

Goodwill

The changes in the carrying amount of goodwill attributable to each reportable segment for the three month period ended March 31, 2024 is presented in the table below.

	Industrial Technologies and Services		Precision and Science Technologies		Total
Balance at beginning of period	$	4,753.5	$	1,856.2	$	6,609.7
Acquisitions	45.9		—		45.9
Foreign currency translation and other(1)	(30.2)		(15.5)		(45.7)
Balance at end of period	$	4,769.2	$	1,840.7	$	6,609.9

(1)Includes measurement period adjustments

As of both March 31, 2024 and December 31, 2023, goodwill included accumulated impairment losses of $220.6 million within the Industrial Technologies and Services segment.

13

Other Intangible Assets, Net

Other intangible assets as of March 31, 2024 and December 31, 2023 consisted of the following.

	March 31, 2024						December 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Amortized intangible assets
Customer lists and relationships	$	3,325.5	$	(1,643.2)	$	1,682.3	$	3,279.3	$	(1,585.4)	$	1,693.9
Technology	418.6		(195.3)		223.3		413.8		(178.9)		234.9
Tradenames	56.8		(28.9)		27.9		52.2		(27.9)		24.3
Backlog	4.4		(2.2)		2.2		3.0		(1.3)		1.7
Other	121.2		(106.1)		15.1		117.1		(104.1)		13.0
Unamortized intangible assets
Tradenames	1,638.8		—		1,638.8		1,643.3		—		1,643.3
Total other intangible assets	$	5,565.3	$	(1,975.7)	$	3,589.6	$	5,508.7	$	(1,897.6)	$	3,611.1

Intangible Asset Impairment Considerations

As of March 31, 2024 and December 31, 2023, there were no indications that the carrying value of goodwill and other intangible assets may not be recoverable.

Note 7. Supply Chain Finance Program

The Company has agreements with financial institutions to facilitate a supply chain finance program (the “SCF Program”). Under the SCF Program, qualifying suppliers may elect to sell their receivables from the Company to the financial institution. Participating suppliers negotiate arrangements for sale of their receivables directly with the financial institution, and the terms of the Company’s payment obligations are not impacted by a supplier’s participation in the SCF Program. Once a qualifying supplier elects to participate in the SCF Program and reaches an agreement with the financial institution, the supplier elects which individual Company invoices they sell to the financial institution. However, all of the Company’s payments to participating suppliers are paid to the financial institution on the invoice due date, regardless of whether the individual invoice is sold by the supplier to the financial institution. The Company has not pledged any assets as security or provided other forms of guarantees. All outstanding amounts related to suppliers participating in the SCF Program are recorded within “Accounts payable” in our Condensed Consolidated Balance Sheets, and the associated payments are included in “Net cash provided by operating activities” within our Condensed Consolidated Statements of Cash Flows. Included in “Accounts payable” in the Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 were $24.0 million and $24.3 million of outstanding payment obligations, respectively, that were sold to the financial institution by participating suppliers.

Note 8. Accrued Liabilities

Accrued liabilities as of March 31, 2024 and December 31, 2023 consisted of the following.

	March 31, 2024		December 31, 2023
Salaries, wages and related fringe benefits	$	239.0	$	262.4
Contract liabilities	345.4		331.2
Product warranty	65.6		61.9
Operating lease liabilities	42.5		41.6
Restructuring	20.6		15.5
Taxes	75.6		78.4
Accrued interest	12.1		33.1
Other	198.5		171.4
Total accrued liabilities	$	999.3	$	995.5

14

A reconciliation of the changes in the accrued product warranty liability for the three month periods ended March 31, 2024 and 2023 are as follows.

	For the Three Month Period Ended March 31,
	2024		2023
Balance at beginning of period	$	61.9	$	46.2
Product warranty accruals	13.6		8.9
Acquired warranty	—		1.4
Settlements	(9.3)		(3.9)
Foreign currency translation and other	(0.6)		1.5
Balance at end of period	$	65.6	$	54.1

Note 9. Benefit Plans

Net Periodic Benefit Cost

The following table summarizes the components of net periodic benefit cost for the Company’s defined benefit pension plans and other postretirement benefit plans recognized for the three month periods ended March 31, 2024 and 2023.

	Pension Benefits								Other Postretirement Benefits
	U.S. Plans				Non-U.S. Plans
	For the Three Month Period Ended March 31,
	2024		2023		2024		2023		2024		2023
Service cost	$	—	$	—	$	0.7	$	0.6	$	—	$	—
Interest cost	3.5		4.0		2.7		2.7		0.2		0.2
Expected return on plan assets	(3.3)		(3.3)		(2.8)		(2.7)		—		—
Recognition of:
Unrecognized net actuarial loss	—		—		(0.3)		(0.4)		(0.2)		(0.1)
	$	0.2	$	0.7	$	0.3	$	0.2	$	—	$	0.1

The components of net periodic benefit cost other than the service cost component are included in “Other income, net” in the Condensed Consolidated Statements of Operations.

Note 10. Debt

Debt as of March 31, 2024 and December 31, 2023 is summarized as follows.

	March 31, 2024		December 31, 2023
Short-term borrowings	$	1.7	$	1.0
Long-term debt:
Dollar Term Loan B, due 2027(1)(2)	342.9		347.7
Dollar Term Loan, due 2027(1)(2)	890.0		892.3
5.400% Senior Notes, due 2028(1)	498.3		498.2
5.700% Senior Notes, due 2033(1)	992.8		992.6
Finance leases and other long-term debt	14.9		15.2
Unamortized debt issuance costs	(22.3)		(23.4)
Total long-term debt, net, including current maturities	2,716.6		2,722.6
Current maturities of long-term debt	29.6		29.6
Total long-term debt, net	$	2,687.0	$	2,693.0

(1)This amount is net of unamortized discounts. Total unamortized discounts were $9.5 million and $9.9 million as of March 31, 2024 and December 31, 2023, respectively.

15

(2)As of March 31, 2024, the applicable interest rate was approximately 7.18% and the weighted-average interest rate was 7.19% for the three month period ended March 31, 2024.

Senior Notes

On August 14, 2023, the Company completed its issuance of $1,500.0 million in aggregate principal amount of senior unsecured notes comprised of $500.0 million aggregate principal amount of 5.400% Senior Notes due August 2028 (the “2028 Notes”) and $1,000.0 million aggregate principal amount of 5.700% Senior Notes due August 2033 (the “2033 Notes” and, together with the 2028 Notes, the “Notes”). The Company used the proceeds of the offering of the Notes to repay a portion of the amounts outstanding under its Senior Secured Credit Facilities. The Notes were issued pursuant to a base indenture, each dated as of August 14, 2023, between the Company and Deutsche Bank Trust Company Americas, as trustee (the “Trustee”), as supplemented by a 2028 Supplemental Indenture No. 1 with respect to the 2028 Notes and a 2033 Notes Supplemental Indenture No. 1 with respect to the 2033 Notes, each dated as of August 14, 2023, between the Company and the Trustee (collectively, the “Indenture”). The interest payment dates for the Notes are February 14 and August 14 of each year, with interest payable in arrears.

The Notes are senior unsecured obligations of the Company and rank equally in right of payment with all of the Company’s other senior unsecured indebtedness, senior in right of payment to all of the Company’s subordinated indebtedness, and effectively junior to all of the indebtedness and other liabilities of the Company’s subsidiaries (including the obligations of the Company’s subsidiaries under the Senior Secured Credit Facilities and to all of the Company’s secured indebtedness (including the Company’s obligations under the Senior Secured Credit Facilities)) to the extent of the value of the assets securing such secured indebtedness.

Prior to (i) July 14, 2028, in the case of the 2028 Notes, and (ii) May 14, 2033, in the case of the 2033 Notes, the Company may redeem the Notes of a series at its option, in whole or in part, at any time from time to time, at a “make-whole” premium, plus accrued and unpaid interest thereon to, but not including, the redemption date. On or after (i) July 14, 2028, in the case of the 2028 Notes, and (ii) May 14, 2033, in the case of the 2033 Notes, the Company may redeem the Notes of a series at its option, in whole or in part, at any time from time to time, at a price equal to 100% of the principal amount of the Notes of such series to be redeemed, plus accrued and unpaid interest thereon to, but not including, the redemption date. If the Company experiences certain types of change of control transactions, the Company must offer to repurchase the Notes at 101% of the aggregate principal amount of the Notes repurchased (or such higher amount as the Company may determine) plus accrued and unpaid interest thereon to, but not including, the date of repurchase.

The Indenture contains covenants that limit the Company’s (and its subsidiaries’) ability to, among other things: (i) create liens on certain assets; (ii) consolidate, merge, sell or otherwise dispose of all or substantially all of its consolidated assets; and (iii) enter into sale and leaseback transactions with respect to certain assets. The Indenture also contains customary events of default and covenants for an issuer of investment grade debt securities.

Senior Secured Credit Facilities

The Senior Secured Credit Facilities provided senior secured financing consisting of (i) a senior secured term loan facility denominated in U.S. dollars (as refinanced and otherwise modified from time to time prior to February 28, 2020, the “Original Dollar Term Loan”), (ii) a senior secured term loan facility denominated in U.S. dollars (entered into at the time of the Merger, the “Dollar Term Loan B”), and (iii) a senior secured revolving credit facility (as refinanced and otherwise modified from time to time the “Revolving Credit Facility”). The Revolving Credit Facility is available to be drawn in U.S. dollars (“USD”), Euros (“EUR”), Great British Pounds (“GBP”) and other reasonably accepted foreign currencies, subject to certain sublimits for the foreign currencies. On April 21 2023, the Company entered into Amendment No. 9 to the Credit Agreement, which (a) extended the maturity date for the revolving credit commitments from June 28, 2024 to April 21, 2028, (b) increased the aggregate revolving credit commitments from $1,100.0 million to $2,000.0 million, and (c) made certain other corresponding changes and updates. Other than as modified by Amendment No. 9, the loans under the Credit Agreement continue to have the same terms and the parties to the Credit Agreement continue to have the same obligations set forth in the Credit Agreement. The amendment resulted in the write-off of unamortized debt issuance costs of $0.9 million which was recognized in “Loss on extinguishment of debt” in the Condensed Consolidated Statements of Operations. In August 2023, the Company repaid a portion of the Dollar Term Loan B which resulted in the write-off of unamortized discounts and debt issuance costs of $12.6 million, which was recognized in “Loss on extinguishment of debt” in the Condensed Consolidated Statements of Operations.

See Note 11 “Debt” to the consolidated financial statements in the Company’s 2023 Annual Report for further information on the Senior Secured Credit Facilities.

16

As of March 31, 2024, the aggregate amount of commitments under the Revolving Credit Facility was $2,000.0 million and the capacity under the Revolving Credit Facility to issue letters of credit was $400.0 million. As of March 31, 2024, the Company had no outstanding borrowings under the Revolving Credit Facility, no outstanding letters of credit under the Revolving Credit Facility and unused availability under the Revolving Credit Facility of $2,000.0 million.

As of March 31, 2024, we were in compliance with all covenants of our Senior Secured Credit Facilities and our Senior Notes.

Fair Value of Debt

The fair value of the Company's debt instruments at March 31, 2024 was $2.8 billion. The Company measures the fair value of its debt instruments for disclosure purposes based upon observable market prices quoted on public exchanges for similar assets. These fair value inputs are considered Level 2 within the fair value hierarchy. See Note 14, “Fair Value Measurements” for information on the fair value hierarchy.

Note 11. Stock-Based Compensation Plans

The Company has outstanding stock-based compensation awards granted under the 2013 Stock Incentive Plan (“2013 Plan”) and the 2017 Omnibus Incentive Plan (as amended by the First Amendment, dated April 27, 2021, “2017 Plan”) as described in Note 18, “Stock-Based Compensation Plans” to the consolidated financial statements in its 2023 Annual Report.

The Company’s stock-based compensation awards are generally granted in the first quarter of the year and consist of stock options, restricted stock units and performance share units. In some instances, such as death, awards may vest concurrently with or following an employee’s termination.

Stock-Based Compensation

For the three month periods ended March 31, 2024 and 2023, the Company recognized stock-based compensation expense of $14.1 million and $12.1 million, respectively. These costs are included in “Cost of sales” and “Selling and administrative expenses” in the Condensed Consolidated Statements of Operations.

As of March 31, 2024, there was $146.3 million of total unrecognized compensation expense related to outstanding stock options, restricted stock unit awards and performance stock unit awards granted to employees and non-employee directors, as well as 300,000 conditional stock options awarded during the third quarter of 2022 to our Chairman and CEO in which the service date precedes the grant date, and will be granted upon achievement of certain performance targets. These 300,000 stock options have not been included in the Stock Option Awards section below since the grant date has not occurred.

Stock Option Awards

Stock options are granted to employees with an exercise price equal to the fair value of the Company’s per share common stock on the date of grant. Stock option awards typically vest over four years or five years and expire ten years from the date of grant.

A summary of the Company’s stock option (including SARs) activity for the three month period ended March 31, 2024 is presented in the following table (underlying shares in thousands).

	Shares	Weighted-Average Exercise Price (per share)
Stock options outstanding as of December 31, 2023	5,282	$	31.09
Granted	518	90.38
Exercised or settled	(570)	19.68
Forfeited	(19)	53.83
Expired	(2)	31.29
Stock options outstanding as of March 31, 2024	5,209	38.14
Vested as of March 31, 2024	3,699	26.41

17

The following assumptions were used to estimate the fair value of options granted during the three month periods ended March 31, 2024 and 2023 using the Black-Scholes option-pricing model.

	For the Three Month Period Ended March 31,
Assumptions	2024		2023
Expected life of options (in years)	6.3 - 7.5		6.3 - 7.5
Risk-free interest rate	4.3%		4.0% - 4.1%
Assumed volatility	35.1% - 35.2%		36.6%
Expected dividend rate	0.1	%	0.1	%

Restricted Stock Unit Awards

Restricted stock units are granted to employees and non-employee directors based on the market price of the Company’s common stock on the grant date and recognized in compensation expense over the vesting period. A summary of the Company’s restricted stock unit activity for the three month period ended March 31, 2024 is presented in the following table (underlying shares in thousands).

	Shares	Weighted-Average Grant-Date Fair Value
Non-vested as of December 31, 2023	957	$	52.18
Granted	287	90.38
Vested	(384)	47.52
Forfeited	(16)	54.88
Non-vested as of March 31, 2024	844	67.27

Performance Share Unit (“PSUs”) Awards

Annually, during the first quarter, the Company grants TSR PSUs to certain officers in which the number of shares issued at the end of the performance period is determined by the Company’s total shareholder return percentile rank versus the S&P 500 index for the three year performance period. The grant date fair value of these awards is determined using a Monte Carlo simulation pricing model and compensation cost is recognized straight-line over a three year period.

During the third quarter of 2022, the Company granted Special TSR PSUs to its Chairman and CEO that will become earned (but not vested) on the first date during the five year performance period on which the sum of (i) the 60-day volume-weighted average closing price of the Company’s common stock, plus (ii) the cumulative value of any dividends paid during the five year performance period equals or exceeds $81.85. The grant date fair value of these awards is determined using a Monte Carlo simulation pricing model and compensation cost is recognized straight-line over a five year period. The share price performance goal was achieved on March 6, 2024, but the PSUs will not vest until September 1, 2027, generally subject to Mr. Reynal’s continued employment through such date. The Company also granted its Chairman and CEO Special EPS PSUs that are eligible to vest based on the level of compounded annual growth rate of the Company’s Adjusted EPS during the five year performance period. The grant date fair value of these awards is based on the market price of the Company’s common stock on the grant date and recognized as a compensation expense over a 4.3 year period.

A summary of the Company’s performance stock unit activity for the three month period ended March 31, 2024 is presented in the following table (underlying shares in thousands).

	Shares	Weighted-Average Grant-Date Fair Value
Non-vested as of December 31, 2023	1,380	$	49.53
Granted	87	132.98
Change in units based on performance	122	55.84
Vested	(244)	55.84
Non-vested as of March 31, 2024	1,345	54.37

18

The following assumptions were used to estimate the fair value of performance share units granted during the three month periods ended March 31, 2024 and 2023 using the Monte Carlo simulation pricing model.

	For the Three Month Period Ended March 31,
Assumptions	2024		2023
Expected term (in years)	2.8		2.9
Risk-free interest rate	4.5%		4.4	%
Assumed volatility	28.9%		31.8	%
Expected dividend rate	0.1	%	0.1	%

Note 12. Accumulated Other Comprehensive Loss

The Company’s other comprehensive income (loss) consists of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on certain hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges (consisting of interest rate swap and cap contracts), net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 9 “Benefit Plans” and Note 13 “Hedging Activities and Derivative Instruments.”

The before tax income (loss) and related income tax effect are as follows.

	For the Three Month Period Ended March 31,
	2024						2023
	Before-Tax Amount		Tax Benefit (Expense)		Net of Tax Amount		Before-Tax Amount		Tax Benefit (Expense)		Net of Tax Amount
Foreign currency translation adjustments, net	$	(67.4)	$	(6.1)	$	(73.5)	$	46.2	$	(15.4)	$	30.8
Unrecognized losses on cash flow hedges	(0.1)		—		(0.1)		(7.1)		1.8		(5.3)
Pension and other postretirement benefit prior service cost and gain or loss, net	(1.9)		0.5		(1.4)		(0.2)		—		(0.2)
Other comprehensive income (loss)	$	(69.4)	$	(5.6)	$	(75.0)	$	38.9	$	(13.6)	$	25.3

The tables above include only the other comprehensive income (loss), net of tax, attributable to Ingersoll Rand Inc. Other comprehensive income (loss), net, attributable to noncontrolling interest holders was $(0.8) million and $0.9 million for the three month periods ended March 31, 2024 and 2023, respectively, and related entirely to foreign currency translation adjustments.

Changes in accumulated other comprehensive loss by component for the three month periods ended March 31, 2024 and 2023 are presented in the following table net of tax.

	Foreign Currency Translation Adjustments, Net		Cash Flow Hedges		Pension and Other Postretirement Benefit Plans		Total
Balance as of December 31, 2023	$	(248.0)	$	12.2	$	8.2	$	(227.6)
Other comprehensive income (loss) before reclassifications	(70.4)		3.4		(1.0)		(68.0)
Amounts reclassified from accumulated other comprehensive loss	(3.1)		(3.5)		(0.4)		(7.0)
Other comprehensive loss	(73.5)		(0.1)		(1.4)		(75.0)
Balance as of March 31, 2024	$	(321.5)	$	12.1	$	6.8	$	(302.6)

19

	Foreign Currency Translation Adjustments, Net		Cash Flow Hedges		Pension and Other Postretirement Benefit Plans		Total
Balance as of December 31, 2022	$	(282.8)	$	16.0	$	15.1	$	(251.7)
Other comprehensive income (loss) before reclassifications	34.8		(3.8)		0.2		31.2
Amounts reclassified from accumulated other comprehensive loss	(4.0)		(1.5)		(0.4)		(5.9)
Other comprehensive income (loss)	30.8		(5.3)		(0.2)		25.3
Balance as of March 31, 2023	$	(252.0)	$	10.7	$	14.9	$	(226.4)

Reclassifications out of accumulated other comprehensive loss for the three month periods ended March 31, 2024 and 2023 are presented in the following table.

Amount Reclassified from Accumulated Other Comprehensive Loss
Details about Accumulated Other Comprehensive Loss Components	For the Three Month Period Ended March 31,				Affected Line(s) in the Statement Where Net Income is Presented
	2024		2023
Cash flow hedges (interest rate swaps and caps)	$	(4.7)	$	(2.0)	Interest expense
Provision for income taxes	1.2		0.5		Provision for income taxes
Cash flow hedges (interest rate swaps and caps), net of tax	$	(3.5)	$	(1.5)
Net investment hedges	$	(4.2)	$	(5.4)	Interest expense
Provision for income taxes	1.1		1.4		Provision for income taxes
Net investment hedges, net of tax	$	(3.1)	$	(4.0)
Amortization of defined benefit pension and other postretirement benefit items(1)	$	(0.5)	$	(0.5)	Cost of sales and Selling and administrative expenses
Provision for income taxes	0.1		0.1		Provision for income taxes
Amortization of defined benefit pension and other postretirement benefit items, net of tax	$	(0.4)	$	(0.4)
Total reclassifications for the period, net of tax	$	(7.0)	$	(5.9)

(1)These components are included in the computation of net periodic benefit cost. See Note 9 “Benefit Plans” for additional details.

Note 13. Hedging Activities and Derivative Instruments

Hedging Activities

The Company is exposed to certain market risks during the normal course of its business arising from adverse changes in interest rates and foreign currency exchange rates. The Company selectively uses derivative financial instruments (“derivatives”), including cross-currency interest rate swap and foreign currency forward contracts and interest rate swap and cap contracts, to manage the risks from fluctuations in foreign currency exchange rates and interest rates, respectively. The Company does not purchase or hold derivatives for trading or speculative purposes.

The Company’s exposure to interest rate risk results primarily from its variable-rate borrowings. The Company manages its debt centrally, considering tax consequences and its overall financing strategies. The Company manages its exposure to interest rate risk by using interest rate derivatives as cash flow hedges of variable rate debt in order to adjust the relative fixed and variable proportions.

A substantial portion of the Company’s operations is conducted by its subsidiaries outside of the United States in currencies other than the USD. Almost all of the Company’s non-U.S. subsidiaries conduct their business primarily in their local currencies, which are also their functional currencies. The USD, the EUR, GBP, Chinese Renminbi and Indian rupee are the principal currencies in which the Company and its subsidiaries enter into transactions. The Company is exposed to the impacts of changes in foreign

20

currency exchange rates on the translation of its non-U.S. subsidiaries’ assets, liabilities and earnings into USD. The Company manages this exposure by having certain U.S. subsidiaries borrow in currencies other than the USD or utilizing cross-currency interest rate swaps as net investment hedges.

The Company and its subsidiaries are also subject to the risk that arises when they, from time to time, enter into transactions in currencies other than their functional currency. To mitigate this risk, the Company and its subsidiaries typically settle intercompany trading balances at least quarterly. The Company also selectively uses forward currency contracts to manage this risk. These contracts for the sale or purchase of European and other currencies generally mature within one year.

Derivative Instruments

The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023.

March 31, 2024
Derivative Classification		Notional Amount(1)		Fair Value(1) Other Current Assets		Fair Value(1) Other Assets		Fair Value(1) Accrued Liabilities		Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contracts	Cash flow	$	528.5	$	9.5	$	1.4	$	—	$	—
Cross-currency interest rate swap contracts	Net investment	1,054.2		16.7		—		—		39.7

December 31, 2023
Derivative Classification		Notional Amount(1)		Fair Value(1) Other Current Assets		Fair Value(1) Other Assets		Fair Value(1) Accrued Liabilities		Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contracts	Cash Flow	$	528.5	$	8.2	$	1.2	$	—	$	—
Cross-currency interest rate swap contracts	Net investment	1,054.2		15.7		—		—		63.1

(1)Notional amounts represent the gross contract amounts of the outstanding derivatives excluding the total notional amount of positions that have been effectively closed through offsetting positions. The net gains and net losses associated with positions that have been effectively closed through offsetting positions but not yet settled are included in the asset and liability derivatives fair value columns, respectively.

All cash flows related to derivatives for the periods presented are classified as operating cash flows in the Condensed Consolidated Statements of Cash Flows.

There were no off-balance sheet derivative instruments as of March 31, 2024 or December 31, 2023.

Interest Rate Swap and Cap Contracts Designated as Cash Flow Hedges

As of March 31, 2024, the Company was the fixed rate payor on two interest rate swap contracts that effectively fix the SOFR-based index used to determine the interest rates charged on a total of $528.5 million of the Company’s SOFR-based variable rate borrowings. These contracts carry a fixed rate of 3.2% and expire in June 2025. These swap agreements qualify as hedging instruments and have been designated as cash flow hedges of forecasted SOFR-based interest payments. Based on SOFR-based swap yield curves as of March 31, 2024, the Company expects to reclassify gains of $9.6 million out of accumulated other comprehensive income (“AOCI”) into earnings during the next 12 months.

The Company was previously a party to interest rate cap contracts that effectively limited the SOFR-based interest rates charged on a portion of the Company’s variable rate borrowings to 4.0%. The Company and its counterparties terminated these contracts in August 2023. Prior to their termination, these cap contracts qualified as hedging instruments and were designated as cash flow hedges of forecasted interest payments. These forecasted interest payments are still expected to occur as specified in the Company’s hedge designations; therefore, the unrecognized gain at the time of termination will be reclassified into earnings over the remaining period of original term of the contracts, ending in June 2025. The unrecognized gain remaining in AOCI as of March 31, 2024 was $4.8 million, of which $4.2 million is expected to be reclassified into earnings during the next 12 months.

21

Gains (losses) on derivatives designated as cash flow hedges included in the Condensed Consolidated Statements of Comprehensive Income (Loss) for the three month periods ended March 31, 2024 and 2023 are as presented in the table below.

	For the Three Month Period Ended March 31,
	2024		2023
Gain (loss) recognized in OCI on derivatives	$	4.6	$	(5.1)
Gain reclassified from AOCI into income (effective portion)(1)	4.7		2.0

(1)Gains on derivatives reclassified from AOCI into income were included within “Interest expense” in the Condensed Consolidated Statements of Operations.

Cross-Currency Interest Rate Swap Contracts Designated as Net Investment Hedges

As of March 31, 2024, the Company was the fixed rate payor on two cross-currency interest rate swap contracts that replace a fixed rate of 3.2% on a total of $528.5 million with a fixed rate of 1.6% on a total of €500.0 million. These contracts expire in June 2025. These contracts have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.

As of March 31, 2024, the Company entered into three cross-currency interest rate swap contracts where we receive SOFR on a total of $525.7 million and pay EURIBOR on a total of €500.0 million. These contracts expire in June 2025. These contracts have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.

Gains (losses) on derivatives designated as net investment hedges included in the Condensed Consolidated Statements of Comprehensive Income (Loss) for the three month periods ended March 31, 2024 and 2023 are as presented in the table below.

	For the Three Month Period Ended March 31,
	2024		2023
Gain (loss) recognized in OCI on derivatives	$	28.6	$	(5.5)
Gain reclassified from AOCI into income (effective portion)(1)	4.2		5.4

(1)Gains on derivatives reclassified from AOCI into income were included within “Interest expense” in the Condensed Consolidated Statements of Operations.

Foreign Currency Forwards Not Designated as Hedging Instruments

The Company had no foreign currency forward contracts outstanding as of March 31, 2024. These contracts are sometimes used to hedge the change in fair value of recognized foreign currency denominated assets or liabilities caused by changes in currency exchange rates. The changes in the fair value of these contracts generally offset the changes in the fair value of a corresponding amount of the hedged items, both of which are included within “Other operating expense, net” in the Condensed Consolidated Statements of Operations. The Company’s foreign currency forward contracts are subject to master netting arrangements or agreements between the Company and each counterparty for the net settlement of all contracts through a single payment in a single currency in the event of default on or termination of any one contract with that certain counterparty. It is the Company’s practice to recognize the gross amounts in the Condensed Consolidated Balance Sheets.

The Company’s gains on derivative instruments not designated as accounting hedges and total net foreign currency gains (losses) for the three month periods ended March 31, 2024 and 2023 were as follows.

	For the Three Month Period Ended March 31,
	2024		2023
Foreign currency forward contracts gains	$	—	$	0.2
Total foreign currency transaction gains (losses), net	0.7		(1.0)

Note 14. Fair Value Measurements

A financial instrument is defined as cash or cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The

22

Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivables, trade accounts payables, deferred compensation assets and obligations, acquisition related contingent consideration obligations, derivatives and debt instruments. The carrying values of cash and cash equivalents, trade accounts receivables, trade accounts payables, and variable rate debt instruments are a reasonable estimate of their respective fair values.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or more advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows.

Level 1    Quoted prices (unadjusted) in active markets for identical assets or liabilities as of the reporting date.

Level 2    Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.

Level 3    Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023.

	March 31, 2024
	Level 1		Level 2		Level 3		Total
Financial Assets
Trading securities held in deferred compensation plan(1)	$	18.4	$	—	$	—	$	18.4
Interest rate swaps(2)	—		10.9		—		10.9
Cross-currency interest rate swaps(3)	—		16.7		—		16.7
Total	$	18.4	$	27.6	$	—	$	46.0
Financial Liabilities
Deferred compensation plans(1)	$	25.7	$	—	$	—	$	25.7
Cross-currency interest rate swaps(3)	—		39.7		—		39.7
Contingent consideration(4)	—		—		48.4		48.4
Total	$	25.7	$	39.7	$